Starboard Value

CRO

Starboard targets Parexel amid talk of multibillion-dollar sale

Activist investor Starboard Value is demonstrating its confidence in Parexel by disclosing a 5.7% stake buy in the company, immediately after news of the CRO’s potential $4 billion sale went out on the street.

Angus Liu May 11, 2017 9:16am

UPDATED: Angry Depomed investor seeks to oust company’s board

May 26, 2016 10:03am